Fate Therapeutics Inc (FATE): Weighted Average Diluted Shares
118.79M
Year ended 2025-12-31
+7.1%
3-year compound annual growth
+7.6%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 118.79M | +4.5% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | 113.69M | +15.5% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | 98.41M | +1.6% | 2025-03-05, From 2023-01-01 |
| 2022-12-31 | 96.83M | +2.2% | 2024-02-26, From 2022-01-01 |
| 2021-12-31 | 94.75M | +15.0% | 2023-02-28, From 2021-01-01 |
| 2020-12-31 | 82.39M | n/a | 2023-02-28, From 2020-01-01 |